Organogenesis Holdings Inc (ORGO)

$2.39 -0.01 (-0.42%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	308.74M
Revenue (ttm)	564.17M
Net Income (ttm)	37.03M
EPS (ttm)	N/A
PE Ratio	8.89
Forward PE	N/A
Profit Margin	6.56%
Debt to Equity Ratio	0.00

Volume	756,900
Avg Vol	688,968
Day's Range	N/A - N/A
Shares Out	128.64M
Stochastic %K	17%
Beta	1.43
Analysts	Sell
Price Target	$8.00

Company Profile

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds; Apligraf, a bioengineered bi-layered skin substitute for the treatm...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 781 575 0775

Website: organogenesis.com

Address:

85 Dan Road, Canton, United States